[Circulating immune complexes in leukemia]. 1981

C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
October 1985, Rinsho byori. The Japanese journal of clinical pathology,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
January 1989, Neoplasma,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
October 1992, Veterinary immunology and immunopathology,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
January 1980, Ugeskrift for laeger,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
November 1982, The New England journal of medicine,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
January 1985, Cancer immunology, immunotherapy : CII,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
February 1991, Leukemia,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
January 1984, Sovetskaia meditsina,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
October 1977, The Journal of clinical investigation,
C Nicolette, and G Füst, and L Paul-Henri, and M Peter, and Z Hollán
January 1981, Medicinski arhiv,
Copied contents to your clipboard!